» Articles » PMID: 36369900

Circ_0000471 Suppresses the Progression of Ovarian Cancer Through Mediating Mir-135b-5p/dusp5 Axis

Overview
Date 2022 Nov 12
PMID 36369900
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Ovarian cancer (OC) is a common gynecologic cancer with high incidence and mortality. We attempted to investigate the role of circular RNA_0000471 (circ_0000471) in OC progression and its associated mechanism.

Methods: Reverse transcription-quantitative polymerase chain reaction (RT-qPCR) and western blot assay were conducted to measure RNA and protein expression, respectively. Cell proliferation was analyzed by Cell Counting Kit-8 (CCK8) assay, colony formation assay, and 5-Ethynyl-2'-deoxyuridine (EdU) assay. Cell apoptosis was assessed by flow cytometry. Cell migration and invasion were analyzed by wound healing assay and transwell assay, respectively. Dual-luciferase reporter assay and RNA immunoprecipitation (RIP) assay were conducted to verify the target relationships. Xenograft tumor model was established to assess the role of circ_0000471 on tumor growth in vivo.

Results: Circ_0000471 expression was down-regulated in OC tissues and cell lines. Circ_0000471 overexpression blocked the proliferation, migration, and invasion and triggered the apoptosis of OC cells. Circ_0000471 served as a molecular sponge for microRNA-135b-5p (miR-135b-5p), and circ_0000471 overexpression-mediated anti-tumor influences in OC cells were largely reversed by the overexpression of miR-135b-5p. Dual specificity phosphatase 5 (DUSP5) was a target of miR-135b-5p, and miR-135b-5p silencing-induced anti-tumor effects were largely counteracted by the interference of DUSP5. Circ_0000471 increased DUSP5 expression by sponging miR-135b-5p in OC cells. Circ_0000471 overexpression restrained the growth of xenograft tumors in vivo.

Conclusion: Overexpression of circ_0000471 inhibited OC development by targeting miR-135b-5p/DUSP5 axis, indicating that circ_0000471 may be a new potential target for OC treatment.

Citing Articles

Interplay of microRNAs and circRNAs in Epithelial Ovarian Cancer.

Schwarzenbach H Noncoding RNA. 2024; 10(5).

PMID: 39452837 PMC: 11510331. DOI: 10.3390/ncrna10050051.


miR-135b: An emerging player in cardio-cerebrovascular diseases.

Shao Y, Xu J, Chen W, Hao M, Liu X, Zhang R J Pharm Anal. 2024; 14(10):100997.

PMID: 39211791 PMC: 11350494. DOI: 10.1016/j.jpha.2024.100997.


MiR-135b-5p promotes cetuximab resistance in colorectal cancer by regulating FOXN3.

Peng C, Li X, Yao Y, Nie Y, Fan L, Zhu C Cancer Biol Ther. 2024; 25(1):2373497.

PMID: 38967961 PMC: 11229718. DOI: 10.1080/15384047.2024.2373497.


Deregulated circRNAs in Epithelial Ovarian Cancer With Activity in Preclinical Models: Identification of Targets and New Modalities for Therapeutic Intervention.

Weidle U, Birzele F Cancer Genomics Proteomics. 2024; 21(3):213-237.

PMID: 38670587 PMC: 11059596. DOI: 10.21873/cgp.20442.